Accretion Pharmaceuticals Limited IPO Key Performance Indicators and ratios

Accretion Pharmaceuticals IPO Review - Issue Date, Price, GMP, Subscription, Allotment, Lot Size, and Details

IPO Details IPO GMP IPO Subscription Reviews About Company IPO Timeline KPI Financial Information Peer Comparison Allotment

Accretion Pharmaceuticals IPO : Key Performance Indicators, PE Ratio, EPS, ROE, ROCE & RoNW
The Company Key Performance Indicates the pre-issue EPS of ₹ 9.69 and post-issue EPS of ₹ 3.49 for FY24. The pre-issue P/E ratio is 10.42x, while the post-issue P/E ratio is 28.97x against the Industry P/E ratio is 28x. The company's ROCE for FY24 is 36.73%, ROE for FY24 is 72.47% and RoNW is 72.47%. The Annualised EPS based on the latest financial data is ₹ 11.65 and PE ratio is 8.66x. These metrics suggest that the IPO is fairly priced.

Key Performance Indicator
KPI	Values
EPS Pre IPO (Rs.)	₹ 9.69
EPS Post IPO (Rs.)	₹ 3.49
P/E Pre IPO	10.42
P/E Post IPO	28.97
ROE	72.47 %
ROCE	36.73 %
P/BV	5.91
Debt/Equity	2.52
RoNW	72.47 %